ES557768A0 - Un procedimiento para preparar benzo (c)-1,5-naftiridinas - Google Patents

Un procedimiento para preparar benzo (c)-1,5-naftiridinas

Info

Publication number
ES557768A0
ES557768A0 ES557768A ES557768A ES557768A0 ES 557768 A0 ES557768 A0 ES 557768A0 ES 557768 A ES557768 A ES 557768A ES 557768 A ES557768 A ES 557768A ES 557768 A0 ES557768 A0 ES 557768A0
Authority
ES
Spain
Prior art keywords
loweralkyl
naphtiridines
procedure
diarylloweralkyl
arylloweralkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES557768A
Other languages
English (en)
Other versions
ES8801270A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Hoechst Roussel Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharmaceuticals Inc filed Critical Hoechst Roussel Pharmaceuticals Inc
Publication of ES8801270A1 publication Critical patent/ES8801270A1/es
Publication of ES557768A0 publication Critical patent/ES557768A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D207/28—2-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Display Devices Of Pinball Game Machines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
ES557768A 1985-03-13 1987-10-15 Un procedimiento para preparar benzo (c)-1,5-naftiridinas Expired ES8801270A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/711,327 US4652567A (en) 1985-03-13 1985-03-13 Benzo(c)-1,5-naphthyridines useful for treating a patient having drug induced memory impairment in need of memory enhancement

Publications (2)

Publication Number Publication Date
ES8801270A1 ES8801270A1 (es) 1988-01-01
ES557768A0 true ES557768A0 (es) 1988-01-01

Family

ID=24857642

Family Applications (4)

Application Number Title Priority Date Filing Date
ES552874A Expired ES8707528A1 (es) 1985-03-13 1986-03-11 Un procedimiento para preparar benzo (c)-1,5-naftiridinas
ES557207A Expired ES8801269A1 (es) 1985-03-13 1986-11-17 Un procedimiento para preparar benzo(c)-1,5-naftiridinas
ES557208A Expired ES8800941A1 (es) 1985-03-13 1986-11-17 Un procedimiento para preparar derivados de dihidropirrol (112-b)-isoquinoleina
ES557768A Expired ES8801270A1 (es) 1985-03-13 1987-10-15 Un procedimiento para preparar benzo (c)-1,5-naftiridinas

Family Applications Before (3)

Application Number Title Priority Date Filing Date
ES552874A Expired ES8707528A1 (es) 1985-03-13 1986-03-11 Un procedimiento para preparar benzo (c)-1,5-naftiridinas
ES557207A Expired ES8801269A1 (es) 1985-03-13 1986-11-17 Un procedimiento para preparar benzo(c)-1,5-naftiridinas
ES557208A Expired ES8800941A1 (es) 1985-03-13 1986-11-17 Un procedimiento para preparar derivados de dihidropirrol (112-b)-isoquinoleina

Country Status (19)

Country Link
US (1) US4652567A (es)
EP (1) EP0197318B1 (es)
JP (1) JPS61212585A (es)
KR (1) KR860007255A (es)
AT (1) ATE52510T1 (es)
AU (1) AU590748B2 (es)
CA (1) CA1248108A (es)
DE (1) DE3671017D1 (es)
DK (1) DK114386A (es)
ES (4) ES8707528A1 (es)
FI (1) FI861001A (es)
GR (1) GR860681B (es)
HU (2) HU197007B (es)
IL (1) IL78117A0 (es)
NO (1) NO163489B (es)
NZ (1) NZ215439A (es)
PH (1) PH22279A (es)
PT (1) PT82187B (es)
ZA (1) ZA861837B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4766217A (en) * 1984-01-13 1988-08-23 Boehringer Ingelheim Kg Preparation of 5,6-dihydro-pyrrolo[2,1-a]isoquinolines
WO1989002739A1 (en) * 1987-10-05 1989-04-06 Pfizer Inc. 4-aminopyridine derivatives
US5202440A (en) * 1987-10-05 1993-04-13 Pfizer Inc. Certain 9-amino-2-(or 4)-oxa 1,2,3,4-tetrahydro- or 1,2,3,4,5,6,7,8-octahydro-acridines
US5994367A (en) 1997-03-07 1999-11-30 The University Of North Carolina At Chapel Hill Method for treating tumors using 2-aryl-naphthyridin-4-ones

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2273533A1 (fr) * 1974-06-04 1976-01-02 Ferlux Sa Nouveaux derives n-substitues d'acides pyrrolidones-2 carboxyliques-5
US4297358A (en) * 1979-01-16 1981-10-27 Ciba-Geigy Corporation Novel 4,7-phenanthroline derivatives and pharmaceutical compositions containing them and their use
BE880455A (fr) * 1979-01-22 1980-06-06 Sandoz Sa Compositions pharmaceutiques a base d'une benzo (c) (1,6) naphtyridine

Also Published As

Publication number Publication date
EP0197318A1 (en) 1986-10-15
HUT40658A (en) 1987-01-28
FI861001A0 (fi) 1986-03-11
DE3671017D1 (de) 1990-06-13
ES8801269A1 (es) 1988-01-01
DK114386A (da) 1986-09-14
US4652567A (en) 1987-03-24
PT82187A (en) 1986-04-01
AU590748B2 (en) 1989-11-16
ES8801270A1 (es) 1988-01-01
AU5465886A (en) 1986-09-18
HU197007B (en) 1989-02-28
KR860007255A (ko) 1986-10-10
HU201756B (en) 1990-12-28
DK114386D0 (da) 1986-03-12
ES557208A0 (es) 1987-12-01
PT82187B (en) 1988-01-07
IL78117A0 (en) 1986-07-31
GR860681B (en) 1986-07-14
NO860933L (no) 1986-09-15
EP0197318B1 (en) 1990-05-09
NZ215439A (en) 1990-03-27
PH22279A (en) 1988-07-14
NO163489B (no) 1990-02-26
ZA861837B (en) 1987-06-24
CA1248108A (en) 1989-01-03
ES552874A0 (es) 1987-08-01
ATE52510T1 (de) 1990-05-15
ES557207A0 (es) 1988-01-01
ES8800941A1 (es) 1987-12-01
JPS61212585A (ja) 1986-09-20
ES8707528A1 (es) 1987-08-01
FI861001A (fi) 1986-09-14

Similar Documents

Publication Publication Date Title
ES2029812T3 (es) Un procedimiento para preparar alfa-alquil-4-amino-3-quinolina-metanoles y 1-(4-aralquilamino-3-quinolil)alcanonas.
FI921641A0 (fi) Menetelmä lääkeaineina käyttökelpoisten 1-(pyrido/3,4-b/-1,4-oksatsin-4-yyli)-1H-indolien valmistamiseksi
ES557207A0 (es) Un procedimiento para preparar benzo(c)-1,5-naftiridinas
NO874872L (no) Kondenderte heterocykliske tetrahydroaminokinolinoler og beslektede forbindelser samt fremgangsmaate for fremstilling derav.
ES2064533T3 (es) Acido(1,2,3,4-tetrahidro-9-acridinimino)-ciclohexanocarboxilico y compuestos relacionados, un procedimiento para su preparacion y su uso como medicamentos.
DK592589D0 (da) Kondenserede heterocycliske derivater af 1,2,3,4-tetrahydroacridin, deres fremstilling og anvendelse
NO911998L (no) Pyrido(3,4-b)(pyrrolo(1,2-e)(1,4,5)oksadiazepin og beslektede analoger og fremgangsmaate for fremstilling derav.
IL99168A0 (en) 1-(pyridinylalkyl-1h-indoles,indolines and related analogs

Legal Events

Date Code Title Description
MM4A Patent lapsed

Effective date: 19960401